Viewing Study NCT00805350


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-04-16 @ 5:07 PM
Study NCT ID: NCT00805350
Status: COMPLETED
Last Update Posted: 2016-03-07
First Post: 2008-12-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Insomnia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Insomnia View
None Sleep Maintenance View
None Polysomnography View